Patent details

EP3461847 Title: HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

Basic Information

Publication number:
EP3461847
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP182041525
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
French Title of Invention:
ANTICORPS HUMANISES CONTRE LIV-1 ET LEURS UTILISATIONS POUR TRAITER LE CANCER
German Title of Invention:
HUMANISIERTE ANTIKÖRPER GEGEN LIV-1 UND DEREN VERWENDUNG ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
06/12/2011
Grant date:
23/09/2020
EP Publication Date:
03/04/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/09/2020
EP B1 Publication Date:
23/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/12/2020
Expiration date:
06/12/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/10/2020
 
 

Name:
Seagen Inc.
Address:
21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

History of Owners

From:
16/09/2020
To:
30/10/2020

Name:
Seattle Genetics, Inc.
Address:
21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:
ARTHUR, William
Address:
United States (US)

2

Name:
NESTEROVA, Albina
Address:
United States (US)

3

Name:
SMITH, Maria Leia
Address:
United States (US)

4

Name:
SUSSMAN, Django
Address:
United States (US)

Priority

1

Priority Number:
42029110 P
Priority Date:
06/12/2010
Priority Country:
United States (US)

2

Priority Number:
201161446990 P
Priority Date:
25/02/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 35/00; C07K 16/28; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
202039
Publication date:
23/09/2020
Description:
Grant (B1)

2

Issue number:
202049
Publication date:
02/12/2020
Description:
Transfer of Rights

3

Issue number:
202115
Publication date:
14/04/2021
Description:
Priority information

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages